Medicare Enrolled

Dr. Christie Matter, MD

Dermatology · Prosper, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1030 S COIT RD, Prosper, TX 75078
9727693376
In practice since 2006 (20 years)
NPI: 1598745465 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Matter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Matter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Matter

Dr. Christie Matter is a dermatology specialist in Prosper, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Matter performed 3,304 Medicare services across 1,766 unique beneficiaries.

Between the years covered by Open Payments, Dr. Matter received a total of $14,982 from 45 pharmaceutical and/or device companies across 597 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Matter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 37% volume in TX $14,982 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,304
Medicare services
Top 37% in TX for dermatology
1,766
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~165 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 1,288 $5 $13
Office visit, established patient (30-39 min) 712 $79 $249
Destruction of precancerous skin growth, 1 374 $39 $131
Destruction of skin growths (warts/lesions), 1-14 227 $71 $221
Skin biopsy, tangential 194 $58 $197
Office visit, established patient (20-29 min) 85 $58 $176
New patient office visit (45-59 min) 71 $93 $323
Biopsy of related skin growth, each additional growth 64 $35 $98
Office visit, established patient (10-19 min) 54 $32 $109
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm 39 $216 $593
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm 37 $73 $238
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm 33 $89 $477
Destruction of precancer skin growth, 15 or more growths 25 $114 $329
Steroid injection (triamcinolone) 23 $1 $2
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm 19 $91 $267
Biopsy of ear 19 $49 $188
Destruction of skin growth, 15 or more growths 14 $72 $258
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm 13 $83 $240
New patient office visit (30-44 min) 13 $56 $218
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,982
Total received (2018-2024)
Avg $2,140/year across 7 years
Top 17% in TX for dermatology
45
Companies
597
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,982 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,451
2023
$1,974
2022
$1,609
2021
$2,093
2020
$1,882
2019
$2,252
2018
$2,721

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Ortho Dermatologics, a division of Bausch Health US, LLC
$3,096
Regeneron Healthcare Solutions, Inc.
$1,214
Novartis Pharmaceuticals Corporation
$1,140
ABBVIE INC.
$1,077
Janssen Biotech, Inc.
$910
Sun Pharmaceutical Industries Inc.
$804
AbbVie Inc.
$753
LEO Pharma Inc.
$642
AbbVie, Inc.
$615
Encore Dermatology Inc.
$542
Amgen Inc.
$517
GENZYME CORPORATION
$380
Galderma Laboratories, L.P.
$366
SUN PHARMACEUTICAL INDUSTRIES INC.
$350
Lilly USA, LLC
$330
UCB, Inc.
$279
PFIZER INC.
$208
VYNE Pharmaceuticals Inc.
$171
MAYNE PHARMA INC.
$156
Almirall LLC
$153
Mayne Pharma Inc.
$147
PruGen, Inc. Pharmaceuticals
$145
E.R. Squibb & Sons, L.L.C.
$145
EPI Health, LLC
$86
DERMIRA, INC.
$85
Taro Pharmaceuticals USA, Inc.
$80
Incyte Corporation
$76
Allergan, Inc.
$71
Merz North America, Inc.
$65
Celgene Corporation
$59
Biofrontera Inc.
$39
Arcutis Biotherapeutics, Inc.
$38
DUSA Pharmaceuticals, Inc.
$36
Genentech USA, Inc.
$30
MAYNE PHARMA COMMERCIAL LLC
$29
Sandoz Inc.
$21
TARO PHARMACEUTICALS USA, INC.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Dermavant Sciences, Inc.
$15
Aclaris Therapeutics, Inc.
$14
Mylan Pharmaceuticals Inc.
$13
Journey Medical Corporation
$13
Nabriva Therapeutics, plc
$13
Merck Sharp & Dohme Corporation
$11
Promius Pharma LLC
$11
Top 3 companies account for 36.4% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BRYHALI · Bensal HP · COSENTYX · Cabtreo · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · Cordran Tape · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Erivedge · FINACEA · HALOG · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · KERYDIN · Klisyri · LEVULAN KERASTICK · LIBTAYO · ODOMZO · ONEXTON · OPZELURA · ORACEA · Otezla · PICATO · Promiseb Complete · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sitavig · Sivextro · Sotyktu · TALTZ · TREMFYA · Tremfya · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VTAMA · Winlevi · XIMINO · ZILXI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $453 per 100 Medicare services performed
Looking for a dermatology specialist in Prosper?
Compare dermatologists in the Prosper area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
113
Per 100K population
10.1
County median income
$117,588
Nearest hospital
COOK CHILDRENS MEDICAL CENTER PROSPER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Matter is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Matter experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Matter performed 1,288 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Matter receive payments from pharmaceutical companies?
Yes. Dr. Matter received a total of $14,982 from 45 companies across 597 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Matter's costs compare to other dermatologists in Prosper?
Dr. Matter's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Matter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →